Bootcamp.bio
  • HOME
  • HISTORY
  • 2025 AGENDA
  • 2025 PRESENTATIONS
  • PUBLICATIONS
  • PEOPLE
    • LEADERSHIP
    • FACULTY
    • PAST REGIONAL CO-CHAIRS
  • CONTACT
  • ARCHIVE
    • 2024 Presentations
    • 2023 Presentations
    • 2022 Boot Camp Agenda and Presentations
    • 2019 Boot Camp Agenda and Presentations
    • 2018 Boot Camp Agenda and Presentations
    • 2017 Boot Camp Agenda and Presentations
  • Search
  • Menu Menu

History

Empowering Innovation: Biotechnology Entrepreneurship Boot Camp Overview

The Biotechnology Entrepreneurship Boot Camp was founded by Professors Arthur Boni, Steve Sammut, and Jeffrey Libson, marking a pioneering initiative to merge scientific innovation with entrepreneurial success. Originating at the BIO Annual Meeting in 2005, this program has expanded its reach, catering to a broad spectrum of entrepreneurs beyond its initial focus on Chief Scientific Officers (CSOs).

Purpose-Driven Education

Established to address a significant knowledge void in the biotech sector, the Boot Camp equips participants with essential skills to turn innovative ideas into thriving businesses. In its early stages, the program collaborated with the now-defunct Pepper Hamilton, LLP, reflecting a commitment to foundational legal and business insights in partnership with the Biotechnology Innovation Organization’s Academic-Industry Committee. This foundation has made the program a cornerstone for budding entrepreneurs.

Inclusive Growth and Strategic Thinking

Emphasizing that entrepreneurial success is attainable for anyone with strategic foresight and effective management, the Boot Camp covers critical areas like project selection, stakeholder engagement, and the intricacies of commercialization. It aims to cultivate the necessary insight and energy for navigating the entrepreneurial journey.

Collaborative Excellence

Featuring a core team of founding faculty alongside regional experts, the curriculum thrives on diversity and expertise, fostering a learning environment ripe for continuous enhancement. This approach ensures that each Boot Camp iteration offers fresh, strategic insights into biotech entrepreneurship.

Impact and Legacy

The Boot Camp has cemented its status as a pivotal platform for emerging leaders in the biotech industry, demonstrated by the achievements of its alumni. It remains dedicated to equipping participants with the comprehensive tools and knowledge needed to tackle the biotech sector’s challenges, thereby driving innovation and entrepreneurial success.

To facilitate and incorporate local participation, local Co-chairs are recruited each year. In previous years, the local Co-Chairs were:

Chicago, IL 2006

Panayiotis P. Constantinides, PhD, Principal, Biopharmaceutical & Drug Delivery Consulting Elsie Quaite-Randall, PhD, MBA, Executive Director of the Office of Research Contracts and IP, McMaster University, formerly of Office of Technology Transfer, Argonne National Laboratory

Boston, MA 2007

Robert Creeden, Partner, HealthCare Systems, Inc., Managing Director, Center for Innovative Ventures

San Diego, CA 2008

Kurt A. May, MBA, Assistant Dean, Executive Development Center, Rady School of Management, University of California, San Diego Duane J. Roth, Chief Executive Officer and Member of the Board of CONNECT.  Steve Flaim, PhD, FACC, FAHA, Chairman Emeritus, Tech Coast Angels, Director, Angel Capital Association

Atlanta, GA 2009

Frank R. Hunt, MS, MBA, President, SE bioStrategies, Inc., CEO, PNP Therapeutics, Inc.
Dennis P. Schafer, CEO, Life Science Management

Chicago, IL 2010

Patrick G. Morand, Managing Director, SWMF Life Science Fund
Charles B. Hoslet, Managing Director, UW-Madison Office of Corporate Relations
Allen J. Dines, Assistant Director, Office of Corporate Relations, University of Wisconsin

Washington, DC 2011

Elana Fine, Director of Venture Investments, Dingman Center for Entrepreneurship, Robert H. Smith School of Business, University of Maryland Toby Gordon, ScD, Associate Professor, The Johns Hopkins Carey Business School Martha J. Connolly, PhD, Director, Maryland Industrial Partnerships, University of Maryland

Boston, MA 2012

Ashley J. Stevens, DPhil (Oxon), CLP, President, Focus IP Group, LLC and Lecturer, Strategy and Innovation Department, School of Management, Boston University
Rekha Paleyanda, PhD, Sr. Business Strategy and Licensing Manager, Partners Healthcare

Chicago, IL 2013

Patrick G. Morand, Managing Partner, Open Prairie Ventures
Allen J. Dines, Assistant Director, Office of Corporate Relations & Venture Designer, Hybrid Zone X, University of Wisconsin-Madison

San Diego, CA 2014

Kurt A. May, MBA, Co-founder and Chairman, Psynomics Incorporated

Larry Stambaugh, Founding Principal, Aperçu Partners

Justin Chakma, Associate Director, Auspex Pharmaceuticals and Thomas, McNerney & Partners, LLC

Philadelphia, PA 2015

Dennis Gross, MS, PhD, CEO, Pennsylvania Drug Discovery Institute at The Pennsylvania Biotechnology Center

James Jordan, MBA, CHT, Chief Investment Officer, Pittsburgh Life Sciences Greenhouse, Distinguished Service Professor in Healthcare & Biotechnology Management, Carnegie Mellon University

Alex B. Reitz, PhD, CEO, Fox Chase Chemical Diversity Center, Inc., The Pennsylvania Biotechnology Center

San Francisco, CA 2016

Benjamin Chen, PhD, Managing Director, Ignatius Transaction Partners

Moira Gunn, PhD, Host, NPR – BioTech Nation, Director, Business of Biotechnology Program,
Professor, School of Management, University of San Francisco

San Diego, CA 2017

Steve Flaim, PhD, FACC, FAHA, Chairman Emeritus, Tech Coast Angels, Director, Angel Capital Association

Larry Stambaugh, Founding Principal, Aperçu Partners, Founding Principal, Aperçu Partners, Chairman, Molecular Assemblies, Inc., Chairman, MindXSciences, Inc., LifeTime Director, BioCom, Chairman, ParaNetics

Boston, MA 2018

Edward Ross, Jr., MBA, President and CEO, ReadyDock, Inc., Member, MassMedical Angels and Launchpad Venture Group

Amy Siegel, MA, Co-founder and President, S2N Health

Philadelphia, PA 2019

Wendy DiCicco, Board Member, Carmell Therapeutics

Kathryn Doyle, PhD, JD, Partner, Saul Ewing Arnstein & Lehr, LLP

Hank Safferstein, PhD, JD, MBA, Senior Vice President, Cognition Therapeutics

San Diego, CA 2022

Jessica Gibson CEO & Co-founder,
Ariel Precision Medicine

Rupak Doshi, Ph.D CEO, OmniSync Incorporated

John York, PharmD, MBA\ Principal & CEO, AKITA BIOMEDICAL Lecturer,
RADY, IGE/JACOBS (UCSD), ORFALEA COLLEGE OF BUSINESS, CAL POLY, SLO
Adj. Professor
ERNEST MARIO (RUTGERS)

Boston, MA 2023

Regional Co-Chairs

Maria Shepherd, MBA

CEO & President, Medi- Vantage

Kristina Zakurdavea, MD, PhD

Founder & Chair of the Board at Foundation for Cancer Research Support

San Diego, CA 2024

John M. York, PharmD, MBA, PhDc

Principal & CEO, Akita Biomedical Lead
Instructor, Institute for the Global Entrepreneur (UCSD)
Adj. Prof, Ernest Mario School of Pharmacy (RUTGERS)

Mike Lemcke

Associate Director, Venture Catalyst, University of California, Davis

Register Now!

Saturday June 14 – Sunday June 15, 2025

Boston Convention and Exhibition Center

Add this course to your
BIO International Registration

REGISTER NOW

Register Now!

Saturday June 14 – Sunday June 15, 2025

Boston Convention and Exhibition Center
(415 Summer St. Boston, MA 02210)
In the Seaport District of Boston, MA

Add this course to your
BIO International Registration

REGISTER NOW
2025 AGENDA 2025 PRESENTATIONS HISTORY PREV. CAMPS RESOURCES
Copyright 2025 © StraTactic, Inc.
Scroll to top